- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-04-02-2014
Pharmaceutical Technology
Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
April 02, 2014
API Synthesis & Manufacturing
38
4
Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
Drug Discovery Partnerships between UK CROs and the Swiss Pharma Sector
April 02, 2014
Drug Discovery
38
4
The international pharmaceutical industry is changing its approach to R&D and is increasingly relying on outsourcing for drug discovery.
SyncOperations Software Helps Increase Workflow
April 02, 2014
Product Spotlight
38
4
SyncOperations Software Helps Increase Workflow
Through-Vial Impedance Spectroscopy: A New In-Line Process Analytical Technology for Freeze Drying
April 02, 2014
Peer-Reviewed
38
4
A new process analytical technology based on impedance spectroscopy has potential applications for characterizing product attributes during the freeze-drying process.
Drug Encapsulation for Patient-Centric Dosing
April 02, 2014
Formulation
38
4
Encapsulation technologies for solubility/bioavailability enhancement, controlled release, and formulation of drug combinations and patient-friendly dosage forms.
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material Considerations
April 02, 2014
Featured Content
38
4
USP evaluates raw materials used in the chemical synthesis of peptides.
The Benefits of eClinical Systems in Supply-Chain Management
April 02, 2014
Ask the Expert
38
4
Kurt Lumsden, Director, eCDS Client Services at PAREXEL Informatics, discusses eClinical supply-chain management.
Navigating the Regulatory Landscape of Combination Products
April 02, 2014
Formulation
38
4
Mark D. Kramer talks about combination products from a regulatory perspective and explains the implications of FDA's final rule on current GMP requirements for combination products.
Increased Efficiency Key to Competitiveness in Downstream Bioprocessing
April 02, 2014
Cover Story
38
4
Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.
Publishing Beyond the Printed Page
April 02, 2014
From The Editor
38
4
More media options open publishing opportunities for drug development experts.
Global Instability Affects the Pharma Market in Brazil
April 02, 2014
Global Feature
38
4
How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?
Q&A with Graham Reynolds, West Pharmaceutical Services
April 02, 2014
Industry Leaders: Q&A
38
4
Graham Reynolds of West Pharmaceutical discusses glass versus plastic packaging.
FDA and Manufacturers Seek a More Secure Drug Supply Chain
April 02, 2014
Regulatory Watch
38
4
New identifiers and tracking requirements aim to block illegitimate products.
Evaluating the Sterile Barrier of Complex Drug Delivery Systems
April 02, 2014
Troubleshooting
38
4
Methods of validating and assuring container closure integrity are crucial for quality assurance.
Arc View Handheld Mobile Sensor Enhances Measurements
April 02, 2014
Product Spotlight
38
4
Arc View Handheld Mobile Sensor Enhances Measurements
CLARiSUITE Software Improves Accessibility and Productivity
April 02, 2014
Product Spotlight
38
4
CLARiSUITE Software Improves Accessibility and Productivity
Multirobot Offline Programming Software Allows 3-D Simulation
April 02, 2014
Product Spotlight
38
4
Multirobot Offline Programming Software Allows 3-D Simulation
Biopharma Outsourcing Activities Update
April 02, 2014
Outsourcing Outlook
38
4
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
Quality by Design—Bridging the Gap between Concept and Implementation
April 02, 2014
Regulatory Watch
38
4
As Europe strives to firmly incorporate quality-by-design principles, there are several key issues that still need to be addressed.
Tackling challenges in the development of fixed-dose combinations
April 02, 2014
Formulation
38
4
Anil Kane from Patheon spoke to Pharmaceutical Technology about the challenges in the development of FDCs and discussed how to integrate quality-by-design (QbD) in the manufacturing process of FDCs.
Pharmaceutical Technology, April 2014 Issue (PDF)
April 02, 2014
Issue PDF
38
4
Click the title above to open the Pharmaceutical Technology April 2014 issue in an interactive PDF format.